Skip to main content

Resource Library


15 April 2025

Chinese Responses to U.S.-China Trade War

Blog
In response to U.S. tariffs on Chinese goods, Beijing announced on April 11 that it will raise its tariffs on American goods to 125%.
19 February 2025

Beijing Holds Private Enterprise Symposium, Signaling Support for the Chinese Private Sector

Blog
On February 17, 2025, the government of the People’s Republic of China (PRC) convened the latest private enterprise symposium in Beijing.
16 December 2024

Hong Kong’s Eroding Autonomy Adds Risks to Its Business Environment

Blog
In November, 45 Hong Kong politicians, activists, union officials, academics, and student leaders were sentenced to up to 10 years in prison on the charge of subversion under the national security laws of the People’s Republic of China (PRC) and the Hong Kong Special Administrative Region (HKSAR).
12 December 2024

PRC Initiates Unreliable Entity List Investigation Against PVH Group

Blog
On September 24, 2024, the Ministry of Commerce (MOFCOM) of the People’s Republic of China (PRC) announced that it was initiating an investigation into the practices of the U.S. PVH Group in accordance with Article 2 of the PRC’s “Provisions on Unreliable Entity List [UEL]” (不可靠实体清单规定, UEL Provisions).
04 November 2024

New PRC Cyber Data Security Regulations Will Impact U.S. Sensitive Data in China

Blog
On 24 September, the State Council of the People’s Republic of China (PRC) issued the order to promulgate the “Regulations on the Management of Network Data Security” (网络数据安全管理条例), hereafter referred to as Cyber Data Security Regulations).
06 August 2024

How to create and execute the optimum China investment strategy

Blog
With growing foreign direct investment in China, it’s essential that U.S. companies get their China investment strategy right to minimize risk and maximize reward. Fortunately, Pamir are experts in guiding U.S. companies with their China investment strategy.
30 July 2024

How does Pamir help get your China business strategy right?

Blog
As trade tensions between the United States and China escalate, it’s essential to get your China business strategy right. Pamir has decades of experience as a China business strategy partner to hundreds of U.S. companies.
16 July 2024

The forthcoming U.S. BIOSECURE Act is already making an impact on the China business strategy of global pharmaceutical companies. What are the implications for your China risk exposure?

Blog
Biopharmaceutical companies worldwide have expressed their intentions to continue investing in China. However, the forthcoming U.S. BIOSECURE Act means that many are proactively reassessing their China business strategies. Pamir has been working with pharma
14 May 2024

China’s MSS Issues Procedural Rules for Law Enforcement and Criminal Cases

Blog
China’s Ministry of State Security (MSS) published two new regulations regarding procedures for law enforcement and processing of criminal cases on 26 April. Both regulations have the force of law and will go into effect on 1 July 2024.
06 March 2024

USTR Report Details Beijing’s Non-Market Practices 

Blog
Two decades of participation in the World Trade Organization have failed to alter China’s centralized approach of pursuing trade policies and practices that advantage Chinese economic interests.
01 March 2024

China Risks Drive Taiwan’s Declining Investments 

Blog
Once a mainstay of Taiwan investment, China has become increasingly unattractive to small- and medium-sized businesses that now seek to pull out completely within five years and invest elsewhere.
23 February 2024

Beijing Tightens Financial Oversight

Blog
Pamir posits that the appointment of WU Qing as the new chair of the China Securities Regulatory Commission signals further tightening of financial oversight and an attempt to restore order in China’s financial industry. 
13 February 2024

China Pharma Market Demand for Diabetes and Weight Loss Drugs Expands

Blog
On 26 January China’s National Medical Products Administration announced that it had approved Novo Nordisk’s Rybelsus treatment for Type-2 diabetes, making it the first orally administrated GLP-1 receptor agonist drug available in the burgeoning Chinese market.
12 February 2024

China Ups Ante in Quantum Computing Global Competition

Blog
Chinese scientists believe the success of domestic firm Origin Quantum’s computer development has given China “a ticket” to global quantum computing competition, despite restrictions imposed by the US on quantum computing chip and technology exports.
07 February 2024

Who is China’s Presumptive New Foreign Minister Liu Jianchao?

Blog
China is likely to announce the appointment of a new foreign minister in March, but the appointee may find his authority circumscribed by highly centralized policymaking.
ANALYST PAPER - CHINA AND RUSSIA COOPERATION

How are China and Russia advancing their shared agendas?

Download our recent analyst paper to understand the key implications of recent China-Russia diplomatic developments.


Resource Library

17 April 2025

Vietnam and other ASEAN countries offer increasingly attractive investment opportunities for U.S. companies

Blog
ASEAN, and particularly Vietnam, is seen as an increasingly attractive opportunity for U.S. companies, highlighted by the visit to Hanoi of the largest U.S. delegations of senior executives from U.S. companies ever.
15 April 2025

Chinese Responses to U.S.-China Trade War

Blog
In response to U.S. tariffs on Chinese goods, Beijing announced on April 11 that it will raise its tariffs on American goods to 125%.
09 April 2025

Asian countries take big tariff hits, but the semiconductor and pharma industries remain exempt… for now

Blog
The sweeping trade tariffs imposed by President Trump have sent global stock markets into turmoil. The APAC region has been hit particularly hard. But, for now, the semiconductor and pharma industries have been granted exemptions. How long will that last?
Make contact with Pamir

Ready to get started on your
China strategy?

Get in touch with us